SpringWorks Therapeutics Inc (NASDAQ: SWTX) closed the day trading at $50.34 up 1.19% from the previous closing price of $49.75. In other words, the price has increased by $+0.59 from its previous closing price. On the day, 720755 shares were traded. SWTX stock price reached its highest trading level at $50.90 during the session, while it also had its lowest trading level at $49.40.
Ratios:
For a better understanding of SWTX, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 6.37 and its Current Ratio is at 6.41. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Guggenheim on February 05, 2024, initiated with a Buy rating and assigned the stock a target price of $75.
On December 01, 2022, BofA Securities started tracking the stock assigning a Buy rating and target price of $45.
H.C. Wainwright reiterated its Buy rating for the stock on January 19, 2021, while the target price for the stock was revised from $87 to $101.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 16 when Pichl Daniel sold 15,000 shares for $50.10 per share. The transaction valued at 751,550 led to the insider holds 45,212 shares of the business.
Ashar Bhavesh sold 4,834 shares of SWTX for $238,435 on Feb 05. The Chief Commercial Officer now owns 58,154 shares after completing the transaction at $49.32 per share. On Feb 02, another insider, Pichl Daniel, who serves as the Chief People Officer of the company, sold 26,181 shares for $44.32 each. As a result, the insider received 1,160,362 and left with 45,212 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SWTX now has a Market Capitalization of 3.71B and an Enterprise Value of 3.24B. For the stock, the TTM Price-to-Sale (P/S) ratio is 681.58 while its Price-to-Book (P/B) ratio in mrq is 5.91. Its current Enterprise Value per Revenue stands at 595.24 whereas that against EBITDA is -9.50.
Stock Price History:
Over the past 52 weeks, SWTX has reached a high of $53.78, while it has fallen to a 52-week low of $18.00. The 50-Day Moving Average of the stock is 43.30, while the 200-Day Moving Average is calculated to be 30.71.
Shares Statistics:
Over the past 3-months, SWTX traded about 1.40M shares per day on average, while over the past 10 days, SWTX traded about 1.35M shares per day. A total of 73.49M shares are outstanding, with a floating share count of 62.70M. Insiders hold about 15.03% of the company’s shares, while institutions hold 91.71% stake in the company. Shares short for SWTX as of Feb 15, 2024 were 11.41M with a Short Ratio of 8.17, compared to 10.41M on Jan 12, 2024. Therefore, it implies a Short% of Shares Outstanding of 15.53% and a Short% of Float of 18.30%.
Earnings Estimates
Current recommendations for the stock of the company come from 6 analysts. On average, analysts expect EPS of -$1.19 for the current quarter, with a high estimate of -$0.93 and a low estimate of -$1.3, while EPS last year was -$1.18. The consensus estimate for the next quarter is -$1.18, with high estimates of -$0.79 and low estimates of -$1.44.
Analysts are recommending an EPS of between -$3.05 and -$5.97 for the fiscal current year, implying an average EPS of -$4.69. EPS for the following year is -$3.38, with 5 analysts recommending between -$0.47 and -$4.42.
Revenue Estimates
A total of 9 analysts have provided revenue estimates for SWTX’s current fiscal year. The highest revenue estimate was $127.7M, while the lowest revenue estimate was $44M, resulting in an average revenue estimate of $83.89M. In the same quarter a year ago, actual revenue was $5.45M, up 1,440.10% from the average estimate. Based on 6 analysts’ estimates, the company’s revenue will be $258.68M in the next fiscal year. The high estimate is $376.4M and the low estimate is $190.3M. The average revenue growth estimate for next year is up 208.40% from the average revenue estimate for this year.
